Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Lung Cancers

Por Yu, Helena A., Riely, Gregory J.
Publicado em 2013

Role of Immunotherapy for Renal Cell Cancer in 2011

Por George, Saby, Pili, Roberto, Carducci, Michael A., Kim, Jenny J.
Publicado em 2011

Tumor board conferences for multidisciplinary skin cancer management: A survey of US cancer centers

Por Mori, Shoko, Navarrete-Dechent, Cristian, Petukhova, Tatyana A., Lee, Erica H., Rossi, Anthony M., Postow, Michael A., Dunn, Lara A., Roman, Benjamin R., Yin, Vivian T., Coit, Daniel G., Hollmann, Travis J., Busam, Klaus J., Nehal, Kishwer S., Barker, Christopher A.
Publicado no J Natl Compr Canc Netw (2018)

Breast Cancer, Version 3.2013: Featured Updates to the NCCN Guidelines

Por Theriault, Richard L., Carlson, Robert W., Allred, Craig, Anderson, Benjamin O., Burstein, Harold J., Edge, Stephen B., Farrar, William B., Forero, Andres, Giordano, Sharon Hermes, Goldstein, Lori J., Gradishar, William J., Hayes, Daniel F., Hudis, Clifford A., Isakoff, Steven J., Ljung, Britt-Marie E., Mankoff, David A., Marcom, P. Kelly, Mayer, Ingrid A., McCormick, Beryl, Pierce, Lori J., Reed, Elizabeth C., Schwartzberg, Lee S., Smith, Mary Lou, Soliman, Hatem, Somlo, George, Ward, John H., Wolff, Antonio C., Zellars, Richard, Shead, Dorothy A., Kumar, Rashmi
Publicado em 2013

Characterization of Prostate Cancer in a Functional Eunuch

Por Stocking, John J., Fiandalo, Michael V., Pop, Elena A., Wilton, John H., Azabdaftari, Gissou, Mohler, James L.
Publicado no J Natl Compr Canc Netw (2016)

Adjuvant Chemotherapy After Lobectomy For T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?

Por Speicher, Paul J, Gu, Lin, Wang, Xiaofei, Hartwig, Matthew G, D’Amico, Thomas A, Berry, Mark F
Publicado no J Natl Compr Canc Netw (2015)

Metastatic Breast Cancer, Version 1.2012: Featured Updates to the NCCN Guidelines

Por Carlson, Robert W., Allred, D. Craig, Anderson, Benjamin O., Burstein, Harold J., Edge, Stephen B., Farrar, William B., Forero, Andres, Giordano, Sharon Hermes, Goldstein, Lori J., Gradishar, William J., Hayes, Daniel F., Hudis, Clifford A., Isakoff, Steven Jay, Ljung, Britt-Marie E., Mankoff, David A., Marcom, P. Kelly, Mayer, Ingrid A., McCormick, Beryl, Pierce, Lori J., Reed, Elizabeth C., Smith, Mary Lou, Soliman, Hatem, Somlo, George, Theriault, Richard L., Ward, John H., Wolff, Antonio C., Zellars, Richard, Kumar, Rashmi, Shead, Dorothy A.
Publicado em 2012

NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy

Por Hudes, Gary R., Carducci, Michael A., Choueiri, Toni K., Esper, Peg, Jonasch, Eric, Kumar, Rashmi, Margolin, Kim A., Michaelson, M. Dror, Motzer, Robert J., Pili, Roberto, Roethke, Susan, Srinivas, Sandy
Publicado no J Natl Compr Canc Netw (2011)

A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice

Por Pawloski, Pamala A., Brooks, Gabriel A., Nielsen, Matthew E., Olson-Bullis, Barbara A.
Publicado no J Natl Compr Canc Netw (2019)

Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer

Por Vickers, Andrew J.
Publicado em 2013

Pancreatic Adenocarcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines

Por Tempero, Margaret A., Arnoletti, J. Pablo, Behrman, Stephen W., Ben-Josef, Edgar, Benson, Al B., Casper, Ephraim S., Cohen, Steven J., Czito, Brian, Ellenhorn, Joshua D. I., Hawkins, William G., Herman, Joseph, Hoffman, John P., Ko, Andrew, Komanduri, Srinadh, Koong, Albert, Ma, Wen Wee, Malafa, Mokenge P., Merchant, Nipun B., Mulvihill, Sean J., Muscarella, Peter, Nakakura, Eric K., Obando, Jorge, Pitman, Martha B., Sasson, Aaron R., Tally, Anitra, Thayer, Sarah P., Whiting, Samuel, Wolff, Robert A., Wolpin, Brian M., Freedman-Cass, Deborah A., Shead, Dorothy A.
Publicado em 2012

NCCN Guidelines(®) Insights Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines

Por Clark, Peter E., Spiess, Philippe E., Agarwal, Neeraj, Bangs, Rick, Boorjian, Stephen A., Buyyounouski, Mark K., Efstathiou, Jason A., Flaig, Thomas W., Friedlander, Terence, Greenberg, Richard E., Guru, Khurshid A., Hahn, Noah, Herr, Harry W., Hoimes, Christopher, Inman, Brant A., Kader, A. Karim, Kibel, Adam S., Kuzel, Timothy M., Lele, Subodh M., Meeks, Joshua J., Michalski, Jeff, Montgomery, Jeffrey S., Pagliaro, Lance C., Pal, Sumanta K., Patterson, Anthony, Petrylak, Daniel, Plimack, Elizabeth R., Pohar, Kamal S., Porter, Michael P., Sexton, Wade J., Siefker-Radtke, Arlene O., Sonpavde, Guru, Tward, Jonathan, Wile, Geoffrey, Dwyer, Mary A., Smith, Courtney
Publicado no J Natl Compr Canc Netw (2016)

Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life

Por Jacobs, Jamie M., Ream, Molly E., Pensak, Nicole, Nisotel, Lauren E., Fishbein, Joel N., MacDonald, James J., Buzaglo, Joanne, Lennes, Inga T., Safren, Steven A., Pirl, William F., Temel, Jennifer S., Greer, Joseph A.
Publicado no J Natl Compr Canc Netw (2019)

Myelodysplastic Syndromes, Version 2.2015: Featured Updates to the NCCN Guidelines

Por Greenberg, Peter L., Stone, Richard M., Bejar, Rafael, Bennett, John M., Bloomfield, Clara D., Borate, Uma, De Castro, Carlos M., Deeg, H. Joachim, DeZern, Amy E., Fathi, Amir T., Frankfurt, Olga, Gaensler, Karin, Garcia-Manero, Guillermo, Griffiths, Elizabeth A., Head, David, Klimek, Virginia, Komrokji, Rami, Kujawski, Lisa A., Maness, Lori J., O’Donnell, Margaret R., Pollyea, Daniel A., Scott, Bart, Shami, Paul J., Stein, Brady L., Westervelt, Peter, Wheeler, Benton, Shead, Dorothy A., Smith, Courtney
Publicado no J Natl Compr Canc Netw (2015)

Prostate Cancer Screening and Determining the Appropriate Prostate-Specific Antigen Cutoff Values

Por Catalona, William J., Loeb, Stacy
Publicado em 2010

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Por Demmy, Todd L., Gu, Lin, Burkhalter, Jack E., Toloza, Eric M., D'Amico, Thomas A., Sutherland, Susan, Wang, Xiaofei, Archer, Laura, Veit, Linda J., Kohman, Leslie
Publicado no J Natl Compr Canc Netw (2012)

Head and Neck Cancers, Version 1.2015: Featured Updates to the NCCN Guidelines

Por Pfster, David G., Spencer, Sharon, Brizel, David M., Burtness, Barbara, Busse, Paul M., Caudell, Jimmy J., Cmelak, Anthony J., Colevas, A. Dimitrios, Dunphy, Frank, Eisele, David W., Foote, Robert L., Gilbert, Jill, Gillison, Maura L., Haddad, Robert I., Haughey, Bruce H., Hicks, Wesley L., Hitchcock, Ying J., Jimeno, Antonio, Kies, Merrill S., Lydiatt, William M., Maghami, Ellie, McCaffrey, Thomas, Mell, Loren K., Mittal, Bharat B., Pinto, Harlan A., Ridge, John A., Rodriguez, Cristina P., Samant, Sandeep, Shah, Jatin P., Weber, Randal S., Wolf, Gregory T., Worden, Frank, Yom, Sue S., McMillian, Nicole, Hughes, Miranda
Publicado no J Natl Compr Canc Netw (2015)

Penile Cancer: Clinical Practice Guidelines in Oncology

Por Clark, Peter E., Spiess, Philippe E., Agarwal, Neeraj, Biagioli, Matthew C., Eisenberger, Mario A., Greenberg, Richard E., Herr, Harry W., Inman, Brant A., Kuban, Deborah A., Kuzel, Timothy M., Lele, Subodh M., Michalski, Jeff, Pagliaro, Lance, Pal, Sumanta K., Patterson, Anthony, Plimack, Elizabeth R., Pohar, Kamal S., Porter, Michael P., Richie, Jerome P., Sexton, Wade J., Shipley, William U., Small, Eric J., Trump, Donald L., Wile, Geoffrey, Wilson, Timothy G., Dwyer, Mary, Ho, Maria
Publicado em 2013

Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer

Por Saylor, Philip J., Smith, Matthew R.
Publicado em 2010

Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Por Fay, Andre P., de Velasco, Guillermo, Ho, Thai H., Van Allen, Eliezer M., Murray, Bradley, Albiges, Laurence, Signoretti, Sabina, Hakimi, A. Ari, Stanton, Melissa L., Bellmunt, Joaquim, McDermott, David F., Atkins, Michael B., Garraway, Levi A., Kwiatkowski, David J., Choueiri, Toni K.
Publicado no J Natl Compr Canc Netw (2016)